ScripsAmerica, Inc. (SCRCQ)
ScripsAmerica, Inc. operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Clifton, NJ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $14,108. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -15.3%. Its beta of -0.32 implies it has historically moved less than the broad market.
ScripsAmerica, Inc. specializes in crafting and selling non-sterile creams for topical and transdermal pain management. Beyond its product offerings, the company provides medication dispensing support to individual doctors and supplies administrative and billing solutions for independent pharmacies. It also functions as a distributor, supplying pharmaceutical goods to standalone drugstores and other healthcare providers. Established in 2008, ScripsAmerica is based in Clifton, New Jersey. The company initially filed for Chapter 11 bankruptcy protection on September 7, 2016, before its reorganization case was subsequently changed to Chapter 7 liquidation on February 8, 2017.
ScripsAmerica, Inc. is most often compared with the following Healthcare names: